Johnson & Johnson (J&J) Innovative Medicine Korea said that the Ministry of Food and Drug Safety has approved Tremfya ...

Novartis Korea said that the Ministry of Food and Drug Safety has approved a new indication for Kisqali (ingredient: ...

Iope, Amorepacific’s high-performance skincare brand, announced the launch of its latest innovation, the Retinol Reti-jection ...

Noul said it has signed a two-year supply contract worth $975,000 (1.3 billion won) to provide its AI-based malaria ...

Busan will build a public children’s hospital, with construction underway and an opening targeted for 2028.On Monday, Busan ...

Starting on Sept. 22, the national influenza vaccination program will begin with children who require two doses.The Korea ...

The Korean Hospital Association (KHA) said Monday it would host the Korea-Africa Healthcare Summit at 4 p.m. on Sept. 17 at ...

One of the key indicators of Parkinson's disease, a degenerative brain disorder, is “REM sleep behavior disorder (RBD),” ...

Celltrion held “Celltrion Science & Innovation Day 2025” last Friday at the Fairmont Hotel in Yeouido, Seoul, targeting ...

A research team at Seoul National University has developed a gene therapy that accurately corrects the representative ...

Vaxcellbio, a Korean company specializing in immunotherapies, said it has been selected as the lead institution for a 3 billion won ($2.1 million) research project under the National Cancer Center’s s ...

Ubix Therapeutics, a company developing new drugs based on targeted protein degradation (TPD) technology, has successfully ...